No Data
No Data
No Data
No Data
No Data
科濟藥業-B:二零二三年年度報告
Futu NewsApr 18 05:04 ET · Announcements
The CAR-T market is approaching 100 billion dollars: domestic companies ensure “survival”, and multinational companies earn dollars
On March 1 of this year, Keji Pharmaceutical-B (02171)'s CAR-T therapy Zewokie Orense injection (SAKIZE) was officially approved for sale, and the number of CAR-T treatments marketed worldwide has also reached 11. Although some of these products compete with each other in terms of treatment of indications, the rapid growth in sales of leading products is still driving the rapid expansion of the global market. The Zhitong Finance App learned that the global CAR-T cell therapy market is expected to reach US$88.52 billion in 2032. The 100 billion dollar market is in sight, and it continues to boost the market's investment confidence. However, not every product
Zhitong FinanceApr 16 22:16 ET
CARsgen Therapeutics Holdings Limited's (HKG:2171) Last Week's 20% Decline Must Have Disappointed Individual Investors Who Have a Significant Stake
Key Insights The considerable ownership by individual investors in CARsgen Therapeutics Holdings indicates that they collectively have a greater say in management and business strategy The top 9 sha
Simply Wall StApr 15 19:39 ET
Changes in Hong Kong stocks | Keji Pharmaceutical-B (02171) fell sharply by more than 16%. The company's losses of 748 million yuan in 23 narrowed 16.19% year-on-year
Keji Pharmaceutical-B (02171) fell sharply by more than 16%. As of press release, it fell 16.78% to HK$4.77, with a turnover of HK$4.3 million.
Zhitong FinanceApr 14 21:58 ET
Carsgen Therapeutics To Give Cancer Drug Oral Presentation at ASCO 2024
Carsgen Therapeutics Holdings (HKG:2171) said it will give an oral presentation of satricabtagene autoleucel on June 3 at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024, accordin
MT NewswiresApr 12 04:13 ET
Keji Pharmaceutical-B (02171): CT041 abstracts were accepted for oral presentation at the 2024 American Society of Clinical Oncology Annual Meeting
Keji Pharmaceutical-B (02171) issued an announcement. The company's board of directors announced that CT041 (a type of target Claud...
Zhitong FinanceApr 11 06:29 ET
搞经济 抄底 加仓 : Everyday same routine. Asia market closed DJI.US Futures hit up^
HopelessChi : heavily punished since 2020 clampdown. this was the cause of the powerful clan and the impact is now more than 3 years. this market entirely had lost investors
hafiz hassan : Mintak sikit yang awak
No Data
No Data